Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News GlucoTrack, Inc. GCTK

GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It also focuses on developing a wireless module for transmission of measurement data captured by the GlucoTrack model DF-F to a cloud-based server.


Recent & Breaking News (NDAQ:GCTK)

Integrity Applications Provides Commercial Update

GlobeNewswire September 14, 2020

Integrity Applications Expands and Strengthens Team with Appointment of Erez Ben-Zvi as Vice President of Product

GlobeNewswire July 13, 2020

Integrity Applications Announces the Appointment of Yair Briman as Senior Executive Advisor

GlobeNewswire April 22, 2020

Integrity Applications Issues Shareholder Update Letter

GlobeNewswire April 14, 2020

Integrity Applications Announces Closing of $15.0 Million Private Placement

GlobeNewswire February 24, 2020

Integrity Applications Receives CE Mark Approval for Self-Calibration Version of its GlucoTrack® Non-Invasive Glucose Monitoring Device

GlobeNewswire January 21, 2020

Integrity Applications Announces the Appointment of David Malka as President

GlobeNewswire November 20, 2019

Integrity Applications Announces the Appointment of Allen E. Danzig to its Board of Directors and as Chair of the Nominating, Governance and Compensation Committee

GlobeNewswire November 4, 2019

Integrity Applications Announces the Appointment of Robert T. Guest as Senior Advisor Industry Executive to Advise on Global Commercial Strategy

GlobeNewswire May 16, 2019

Integrity Applications Announces GlucoTrack® Customer Experience Program in the Netherlands

GlobeNewswire December 17, 2018

Integrity Applications Announces Executive Leadership Changes

GlobeNewswire October 9, 2018

Integrity Applications Receives First Order from CuraTec Nordic for GlucoTrack®

GlobeNewswire August 14, 2018

Integrity Applications Signs Distribution Agreement for Its GlucoTrack® Glucose Monitoring Device in the Nordic Countries

GlobeNewswire July 25, 2018

Integrity Applications Signs Distribution Agreement for Its GlucoTrack® Non-Invasive Glucose Monitoring Device in the Netherlands

PR Newswire December 28, 2017

Integrity Applications Announces Re-Order of GlucoTrack® Devices

PR Newswire November 1, 2017

Integrity Applications Announces Strategic Corporate Update

Business Wire October 23, 2017

A truly non-invasive glucose monitoring device that may improve diabetes management in patients with type 2 diabetes or prediabetes

PR Newswire September 7, 2017

GlucoTrack® presents an innovation in type 2 diabetes management at the upcoming EASD in Lisbon, Portugal

PR Newswire September 5, 2017

Integrity Applications Announces Close of $12 Million Private Placement

PR Newswire August 2, 2017

Integrity Applications Presents Data Demonstrating that the Accuracy of GlucoTrack® Is Independent of Medication Regime at American Diabetes Association's 77th Scientific Sessions

PR Newswire June 12, 2017